Anne K Jensen1, Gui-Shuang Ying2, Jiayan Huang2, Graham E Quinn3, Gil Binenbaum4. 1. Division of Ophthalmology, The Children's Hospital of Philadelphia, Philadelphia, Pensylvania. 2. Department of Ophthalmology, Scheie Eye Institute, Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pensylvania. 3. Division of Ophthalmology, The Children's Hospital of Philadelphia, Philadelphia, Pensylvania; Department of Ophthalmology, Scheie Eye Institute, Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pensylvania. 4. Division of Ophthalmology, The Children's Hospital of Philadelphia, Philadelphia, Pensylvania; Department of Ophthalmology, Scheie Eye Institute, Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pensylvania. Electronic address: binenbaum@email.chop.edu.
Abstract
BACKGROUND: An association between thrombocytopenia and retinopathy of prematurity (ROP) has been suggested but not been studied longitudinally. We sought to identify the time period in postnatal development during which thrombocytopenia and the subsequent development of severe ROP are associated. METHODS: This was a retrospective case-control study of 100 subjects who received laser photocoagulation for type 1 ROP between 2005 and 2009 and 100 controls with no ROP or only stage 1 ROP. The proportions of infants with thrombocytopenia, defined as a serum platelet level of <150,000/μL, among cases versus controls were compared on a weekly basis from birth through the time of laser during early (postmenstrual age [PMA] weeks 24-28), middle (PMA weeks 29-34), and late (PMA weeks 35-38) time periods. Main outcome measures were odds ratios for the association between thrombocytopenia and type 1 ROP from multivariate logistic regression models adjusted for gestational age, birth weight, culture-proven sepsis, and necrotizing enterocolitis. RESULTS: Thrombocytopenia was significantly associated with severe ROP during PMA weeks 24-28 (adjusted OR, 4.7; 95% CI, 2.0-1.1; P = 0.001) and 29-34 (adjusted OR, 2.8; 95% CI, 1.4-5.6; P = 0.006), but not during weeks 35-38 (adjusted OR, 2.0; 95% CI, 0.9-4.3; P = 0.10). CONCLUSIONS: Thrombocytopenia from birth through 34 weeks' PMA was associated with subsequent severe ROP. This time period corresponds to a period of poor retinal vascular growth, suggesting a possible proangiogenic effect of platelets in normal retinal vascular development in infants at risk for ROP.
BACKGROUND: An association between thrombocytopenia and retinopathy of prematurity (ROP) has been suggested but not been studied longitudinally. We sought to identify the time period in postnatal development during which thrombocytopenia and the subsequent development of severe ROP are associated. METHODS: This was a retrospective case-control study of 100 subjects who received laser photocoagulation for type 1 ROP between 2005 and 2009 and 100 controls with no ROP or only stage 1 ROP. The proportions of infants with thrombocytopenia, defined as a serum platelet level of <150,000/μL, among cases versus controls were compared on a weekly basis from birth through the time of laser during early (postmenstrual age [PMA] weeks 24-28), middle (PMA weeks 29-34), and late (PMA weeks 35-38) time periods. Main outcome measures were odds ratios for the association between thrombocytopenia and type 1 ROP from multivariate logistic regression models adjusted for gestational age, birth weight, culture-proven sepsis, and necrotizing enterocolitis. RESULTS:Thrombocytopenia was significantly associated with severe ROP during PMA weeks 24-28 (adjusted OR, 4.7; 95% CI, 2.0-1.1; P = 0.001) and 29-34 (adjusted OR, 2.8; 95% CI, 1.4-5.6; P = 0.006), but not during weeks 35-38 (adjusted OR, 2.0; 95% CI, 0.9-4.3; P = 0.10). CONCLUSIONS:Thrombocytopenia from birth through 34 weeks' PMA was associated with subsequent severe ROP. This time period corresponds to a period of poor retinal vascular growth, suggesting a possible proangiogenic effect of platelets in normal retinal vascular development in infants at risk for ROP.
Authors: L E Smith; W Shen; C Perruzzi; S Soker; F Kinose; X Xu; G Robinson; S Driver; J Bischoff; B Zhang; J M Schaeffer; D R Senger Journal: Nat Med Date: 1999-12 Impact factor: 53.440
Authors: Ann Hellström; Eva Engström; Anna-Lena Hård; Kerstin Albertsson-Wikland; Björn Carlsson; Aimon Niklasson; Chatarina Löfqvist; Elisabeth Svensson; Sture Holm; Uwe Ewald; Gerd Holmström; Lois E H Smith Journal: Pediatrics Date: 2003-11 Impact factor: 7.124
Authors: Joseph E Italiano; Jennifer L Richardson; Sunita Patel-Hett; Elisabeth Battinelli; Alexander Zaslavsky; Sarah Short; Sandra Ryeom; Judah Folkman; Giannoula L Klement Journal: Blood Date: 2007-10-25 Impact factor: 22.113
Authors: Hannes Sallmon; Natalie Timme; Begüm Atasay; Ömer Erdeve; Georg Hansmann; Yogen Singh; Sven C Weber; Elaine L Shelton Journal: Front Pediatr Date: 2021-02-25 Impact factor: 3.418
Authors: Zi Di Lim; Edwin Pheng; Evelyn Tai Li Min; Hans Van Rostenberghe; Ismail Shatriah Journal: Int J Environ Res Public Health Date: 2021-04-05 Impact factor: 3.390